KemPharm announces two new additions to its senior management team

KemPharm announced that it has named Daniel Gallo, Ph.D., as Senior Vice President of Medical Affairs and Advocacy, and Abbi Maher, J.D., as Vice President of Legal Affairs. Both positions are newly created at KemPharm and continue a series of enhancements to the Company’s leadership to support its transformation into a leading rare disease company. Dr. Gallo joins KemPharm from Jaguar Gene Therapy. Maher joins KemPharm from Cytel.